Appeal of New Hampshire Right to Life

166 N.H. 308
CourtSupreme Court of New Hampshire
DecidedMay 22, 2014
Docket2012-0828
StatusPublished
Cited by4 cases

This text of 166 N.H. 308 (Appeal of New Hampshire Right to Life) is published on Counsel Stack Legal Research, covering Supreme Court of New Hampshire primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Appeal of New Hampshire Right to Life, 166 N.H. 308 (N.H. 2014).

Opinion

Lynn, J.

The petitioner, New Hampshire Right to Life (NHRTL), appeals the New Hampshire Board of Pharmacy’s decision that NHRTL *310 did not have standing to participate in administrative actions involving the renewal of Planned Parenthood of Northern New England’s (PPNNE) limited retail drug distributor license. We affirm.

NHRTL is a New Hampshire non-profit organization opposed to government support, by taxpayer subsidies, of medical clinics that provide abortion services. As such, the petitioner wants to ensure that all state agencies, including the Board of Pharmacy (Board), properly regulate these clinics in the state. PPNNE has operated in New Hampshire for a number of years as a licensed limited retail drug distributor pursuant to a contract with the New Hampshire Department of Health and Human Services (DHHS). See RSA 318:42, VII (Supp. 2013); RSA 318:51-b (Supp. 2013). As a limited retail drug distributor, PPNNE must reapply annually to the Board to renew its licenses, the terms of which run from July 1 to June 30 of each year. See RSA 318:51-b; N.H. ADMIN. RULES, Ph. 601.06.

On April 17, 2012, NHRTL sent a written complaint to the Board, alleging that PPNNE did not have a state contract in place with DHHS and was therefore illegally dispensing prescription drugs at its clinics. In its letter, NHRTL claimed that PPNNE’s contract with DHHS had expired on June 30, 2011, and had not been renewed. On June 18, 2012, PPNNE sent renewal applications for its six clinics to the Board, and on July 2,2012, the Board sent letters to each clinic acknowledging receipt of the application. Each letter stated that the Board would not review the renewal application until August 15, 2012, but notified the clinics that it had “ministerially” renewed its licenses through September 1, 2012.

On August 7, 2012, NHRTL sent a second letter to the Board, opposing renewal of PPNNE’s licenses for a variety of reasons. At the Board’s monthly meeting on August 15, 2012, it voted to table consideration of PPNNE’s license renewal applications until its September meeting, pending receipt of additional information from PPNNE. On September 17,2012, NHRTL sent a third letter to the Board, restating its opposition to the renewal of PPNNE’s licenses. Two days later, at its meeting on September 19, the Board approved PPNNE’s applications to renew the licenses for its six clinics.

In response to the Board’s approval of PPNNE’s licenses, NHRTL filed a motion for a rehearing. In its motion, NHRTL asked the Board to reconsider the renewals of PPNNE’s licenses, again restating the various reasons for its opposition to the renewals. On October 25, 2012, in a letter to NHRTL, the Board’s executive secretary/director denied the request for a rehearing on the grounds that NHRTL “is neither a party nor an aggrieved person in the license renewal proceeding.” The letter also stated that NHRTL could not intervene in the license renewal proceedings, as it had not complied with the applicable statutory provisions necessary to be *311 granted intervenor status. On December 12, 2012, the Board ratified the position taken in the October 25 letter, stating that NHRTL lacked standing to appeal the licensing decisions. This appeal followed.

NHRTL argues that the Board erred in denying its motion for rehearing with respect to PPNNE’s license renewals. It contends that the Board erred in finding that it did not have standing to challenge the renewals because RSA 318:29, 1(b) (Supp. 2013) grants standing to intervene in licensing proceedings to “any person” who files a written complaint alleging misconduct by a licensee. We disagree.

In this case, “[t]he material facts are not in dispute; only their legal effect is in dispute.” ACG Credit Co. v. Gill, 152 N.H. 260, 261 (2005). “The issue of standing is, therefore, a question of law, which we review de 'novo.” Id. In order to address the petitioner’s standing argument, we must engage in statutory interpretation. “In matters of statutory interpretation, we are the final arbiters of the legislature’s intent as expressed in the words of the statute considered as a whole.” Petition of Mooney, 160 N.H. 607, 609 (2010). ‘We interpret statutes not in isolation, but in the context of the overall statutory scheme.” Id. “Our analysis must start with consideration of the plain meaning of the relevant statutes, construing them, where reasonably possible, to effectuate their underlying policies.” Id. at 609-10. “Insofar as reasonably possible, we will construe the various statutory provisions harmoniously.” Id. at 610. “Courts can neither ignore the plain language of the legislation nor add words which the lawmakers did not see fit to include.” Id.

RSA 318:29, 1(b) states: “The board may undertake disciplinary action against any licensee . . . [u]pon written complaint of any person which alleges that a licensee ... has committed misconduct...” Nothing in RSA 318:29,1(b) pertains to licensing requirements or license renewal. 1 Rather, it focuses upon when the Board may take disciplinary action, the type of misconduct sufficient to support disciplinary action, and appropriate actions the Board may take in response to licensee misconduct. An entirely separate statutory section deals with the licensing of limited retail drug distributors like PPNNE. See RSA 318:51-b. That section describes, among other things, the proof that an applicant must provide to the Board in order to be granted that type of license. See RSA 318:51-b, (II)(a)-(d); see also *312 N.H. ADMIN. Rules, Ph 601.03 (listing requirements for application for licensure); 601.06 (renewal applications for limited retail drug distributors).

The only overlap between these two distinct statutory sections is in part IV of the limited retail drug distributor licensing section, which states: “Any person licensed pursuant to this section is subject to the provisions of RSA 318:29.” RSA 318:51-b, IV. NHRTL’s argument that the “any person” language applies not only to complaints regarding an incumbent licensee’s misconduct, but also to challenges to an applicant’s request for an initial or renewal license, is strained. Based upon its plain language, RSA 318:51-b, IV cannot be read as importing the phrase “upon written complaint of any person” from the disciplinary provision of RSA 318:29, 1(b) into the licensing section. Rather, this provision means merely that those who become licensed are subject to disciplinary action, and thus can be the subject of “any person’s” written complaint to the Board. NHRTL’s argument to the contrary is untenable, as it would require that we interpret RSA 318:51-b, IV as if it stated: “Any person licensed or seeking licensure pursuant to this section is subject to the provisions of RSA 318:29.” We are not at liberty to rewrite the statutory text in this fashion. See Petition of Mooney, 160 N.H. at 609-10.

However, even if we were to assume that NHRTL’s interpretation of RSA 318:29,1(b) is correct, and that “any person” who submits a complaint to the Board could

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In re Trust of Mary Baker Eddy
212 A.3d 414 (Supreme Court of New Hampshire, 2019)
In re Estate of Anthony Mesiti
Supreme Court of New Hampshire, 2019
Petition of Sanjeev Lath & a.
154 A.3d 1240 (Supreme Court of New Hampshire, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
166 N.H. 308, Counsel Stack Legal Research, https://law.counselstack.com/opinion/appeal-of-new-hampshire-right-to-life-nh-2014.